3rd Annual Breast Cancer Symposium: The Seasons of Breast Cancer

September 24, 2021 to September 26, 2021
The 3rd Annual Breast Cancer Symposium: The Seasons of Breast Cancer is being organized in collaboration with New York Oncology Hematology (NYOH), The University of Chicago Pritzker School of Medicine, and myMedEd, Inc. With an expanded agenda, this accredited conference will offer 18.5 continuing education credits and is scheduled to be held September 24-26, 2021 at NYOHbcs.com.
Treatment options along with opportunities to tailor therapy for patients with breast cancer are evolving rapidly. Emerging evidence suggests that combination therapy with RT and check point inhibitors, as well as gene expression profiling, specifically the identification of intrinsic molecular subclassifications, and/or the use of novel biomarkers combined with traditional prognostic factors, may enhance treatment and improve outcomes. In addition, several new medications have been approved within the last year, and data on other emerging therapeutics has recently been published.

Novel medication approvals, variations in published guidelines, and the challenges created by the COVID-19 pandemic necessitate evidence-based education to assist practitioners in providing optimal care for their patients with breast cancer.

Target Audience

Medical, surgical, and radiation oncologists as well as primary care physicians, gynecologists, medical professionals and health care professionals with an interest in breast cancer are invited to attend.

Learning Objectives

After completing this activity, participants will be able to:

  • Review the modern surgical approaches addressed in the patient encounter;
  • Discuss updates in breast cancer imaging for earlier detection;
  • Identify therapeutic advances in early and advanced hormone receptor-positive, HER2neu overexpressing, and triple-negative breast cancer;
  • Review advances in radiation therapy and outcomes;
  • Identify risk factors and endocrine interventions in patients’ high risk for developing breast cancer;
  • Discuss the role of hereditary genetics and the implication to the patient and their families.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
CME Coordinator Contact Email: 
Available credit: 
  • 18.50 AMA PRA Category 1 Credit™
  • 18.50 Participation
Event starts: 
09/24/2021 - 8:00am
Event ends: 
09/26/2021 - 6:00pm
Activity opens: 
Activity expires: 
Virtual Conference
Click here to learn more about the 3rd Annual Breast Cancer Symposium!
Contact myMedEd via e-mail here.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at BCS@mymededco.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

  Maria Theodoulou, MD
  Program Director
  Breast Cancer Medicine
  New York Oncology Hematology
  Albany, New York

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and New York Oncology Hematology, PC, and in collaboration with my myMedEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University Of Chicago Pritzker School Of Medicine designates this live activity for a maximum of 18.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professions Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
REGISTRATION: Complete conference information and registration can be accessed by clicking below!
Please login or create an account to proceed.